Literature DB >> 26494654

Enhanced brain release of erythropoietin, cytokines and NO during carotid clamping.

Stephana Carelli1, Giorgio Ghilardi2, Paola Bianciardi2, Elisa Latorre2, Federico Rubino2, Marina Bissi3, Anna Maria Di Giulio2, Michele Samaja2, Alfredo Gorio2.   

Abstract

Although effective and safe, carotid endarterectomy (CEA) implies a reduced blood flow to the brain and likely an ischemia/reperfusion event. The high rate of uneventful outcomes associated with CEA suggests the activation of brain endogenous protection mechanisms aimed at limiting the possible ischemia/reperfusion damage. This study aims at assessing whether CEA triggers protective mechanisms such as brain release of erythropoietin and nitric oxide. CEA was performed in 12 patients; blood samples were withdrawn simultaneously from the surgically exposed ipsilateral jugular and leg veins before, during (2 and 40 min) and after clamp removal (2 min). Plasma antioxidant capacity, carbonylated proteins, erythropoietin, nitrates and nitrites (NOx) were determined. No changes in intraoperative EEG, peripheral and transcranial blood oxygen saturation were detectable, and no patients showed any neurologic sign after the intervention. Antioxidant capacity and protein carbonylation in plasma were unaffected. Differently, erythropoietin, VEGF, TNF-α and NOx increased during clamping in the jugular blood (2 and 40 min), while no changes were observed in the peripheral circulation. These results show that blood erythropoietin, VEGF, TNF-α, and NOx increased in the brain during uncomplicated CEA. This may represent an endogenous self-activated neuroprotective mechanism aimed at the prevention of ischemia/reperfusion damage.

Entities:  

Keywords:  Carotid endarterectomy; Erythropoietin; Neuroprotection; Nitric oxide

Mesh:

Substances:

Year:  2015        PMID: 26494654     DOI: 10.1007/s10072-015-2398-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  40 in total

Review 1.  The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics.

Authors:  Jon O Lundberg; Eddie Weitzberg; Mark T Gladwin
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

2.  Recombinant human erythropoietin pretreatment attenuates heart ischemia-reperfusion injury in rats by suppressing the systemic inflammatory response.

Authors:  Y Shen; Y Wang; D Li; C Wang; B Xu; G Dong; H Huang; H Jing
Journal:  Transplant Proc       Date:  2010-06       Impact factor: 1.066

3.  Acute erythropoietin cardioprotection is mediated by endothelial response.

Authors:  Ruifeng Teng; John W Calvert; Nathawut Sibmooh; Barbora Piknova; Norio Suzuki; Junhui Sun; Kevin Martinez; Masayuki Yamamoto; Alan N Schechter; David J Lefer; Constance Tom Noguchi
Journal:  Basic Res Cardiol       Date:  2011-02-23       Impact factor: 17.165

Review 4.  Emerging biological roles for erythropoietin in the nervous system.

Authors:  Michael Brines; Anthony Cerami
Journal:  Nat Rev Neurosci       Date:  2005-06       Impact factor: 34.870

5.  The association of oxidative stress markers with conventional risk factors in the metabolic syndrome.

Authors:  Gulcan G Korkmaz; Esma Altınoglu; Sabiha Civelek; Volkan Sozer; Füsun Erdenen; Omur Tabak; Hafize Uzun
Journal:  Metabolism       Date:  2013-02-11       Impact factor: 8.694

6.  Protein carbonyl groups as biomarkers of oxidative stress.

Authors:  Isabella Dalle-Donne; Ranieri Rossi; Daniela Giustarini; Aldo Milzani; Roberto Colombo
Journal:  Clin Chim Acta       Date:  2003-03       Impact factor: 3.786

7.  Induction of nitric oxide by erythropoietin is mediated by the {beta} common receptor and requires interaction with VEGF receptor 2.

Authors:  Larysa Sautina; Yuri Sautin; Elaine Beem; Zhuo Zhou; Anna Schuler; Jennafer Brennan; Sergey I Zharikov; Yanpeng Diao; Jorg Bungert; Mark S Segal
Journal:  Blood       Date:  2009-11-20       Impact factor: 22.113

8.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia.

Authors:  Yunjuan Sun; Kunlin Jin; Lin Xie; Jocelyn Childs; Xiao Ou Mao; Anna Logvinova; David A Greenberg
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

9.  Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability.

Authors:  Ofelia María Martínez-Estrada; Elisabeth Rodríguez-Millán; Esther González-De Vicente; Manuel Reina; Senén Vilaró; Myriam Fabre
Journal:  Eur J Neurosci       Date:  2003-11       Impact factor: 3.386

10.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.

Authors:  Mimoun Azzouz; G Scott Ralph; Erik Storkebaum; Lucy E Walmsley; Kyriacos A Mitrophanous; Susan M Kingsman; Peter Carmeliet; Nicholas D Mazarakis
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

View more
  8 in total

1.  Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2017-01       Impact factor: 3.307

2.  Brain adaptation to hypoxia and hyperoxia in mice.

Authors:  Laura Terraneo; Rita Paroni; Paola Bianciardi; Toniella Giallongo; Stephana Carelli; Alfredo Gorio; Michele Samaja
Journal:  Redox Biol       Date:  2016-11-04       Impact factor: 11.799

3.  Grafted Neural Precursors Integrate Into Mouse Striatum, Differentiate and Promote Recovery of Function Through Release of Erythropoietin in MPTP-Treated Mice.

Authors:  Stephana Carelli; Toniella Giallongo; Cristina Viaggi; Zuzana Gombalova; Elisa Latorre; Massimiliano Mazza; Francesca Vaglini; Anna Maria Di Giulio; Alfredo Gorio
Journal:  ASN Neuro       Date:  2016-10-27       Impact factor: 4.146

4.  Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases.

Authors:  Federica Rey; Alice Balsari; Toniella Giallongo; Sara Ottolenghi; Anna M Di Giulio; Michele Samaja; Stephana Carelli
Journal:  ASN Neuro       Date:  2019 Jan-Dec       Impact factor: 4.146

5.  Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson's Disease.

Authors:  Federica Rey; Sara Ottolenghi; Toniella Giallongo; Alice Balsari; Carla Martinelli; Robert Rey; Raffaele Allevi; Anna Maria Di Giulio; Gian Vincenzo Zuccotti; Serena Mazzucchelli; Roberta Foresti; Michele Samaja; Stephana Carelli
Journal:  Antioxidants (Basel)       Date:  2021-01-15

6.  Neural precursors cells expanded in a 3D micro-engineered niche present enhanced therapeutic efficacy in vivo.

Authors:  Stephana Carelli; Toniella Giallongo; Federica Rey; Bianca Barzaghini; Tommaso Zandrini; Andrea Pulcinelli; Riccardo Nardomarino; Giulio Cerullo; Roberto Osellame; Cristina Cereda; Gian Vincenzo Zuccotti; Manuela Teresa Raimondi
Journal:  Nanotheranostics       Date:  2021-01-01

Review 7.  The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review.

Authors:  Yuanyuan Ma; Zhiyuan Zhou; Guo-Yuan Yang; Jing Ding; Xin Wang
Journal:  Front Pharmacol       Date:  2022-02-17       Impact factor: 5.810

Review 8.  Comparative Response of Brain to Chronic Hypoxia and Hyperoxia.

Authors:  Laura Terraneo; Michele Samaja
Journal:  Int J Mol Sci       Date:  2017-09-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.